337 related articles for article (PubMed ID: 37345823)
21. The Presence of Clonal Hematopoiesis Is Negatively Associated with Diabetic Peripheral Neuropathy in Type 2 Diabetes.
Oh TJ; Song H; Koh Y; Choi SH
Endocrinol Metab (Seoul); 2022 Apr; 37(2):243-248. PubMed ID: 35504600
[TBL] [Abstract][Full Text] [Related]
22. Clonal Hematopoiesis of Indeterminate Potential in Chronic Thromboembolic Pulmonary Hypertension: A Multicenter Study.
Liu C; Zhou YP; Lian TY; Li RN; Ma JS; Yang YJ; Zhang SJ; Li XM; Qiu LH; Qiu BC; Ren LY; Wang J; Han ZY; Li JH; Wang L; Xu XQ; Sun K; Chen LF; Cheng CY; Zhang ZJ; Jing ZC
Hypertension; 2024 Feb; 81(2):372-382. PubMed ID: 38116660
[TBL] [Abstract][Full Text] [Related]
23. Clonal Hematopoiesis and Risk of Progression of Heart Failure With Reduced Left Ventricular Ejection Fraction.
Pascual-Figal DA; Bayes-Genis A; Díez-Díez M; Hernández-Vicente Á; Vázquez-Andrés D; de la Barrera J; Vazquez E; Quintas A; Zuriaga MA; Asensio-López MC; Dopazo A; Sánchez-Cabo F; Fuster JJ
J Am Coll Cardiol; 2021 Apr; 77(14):1747-1759. PubMed ID: 33832602
[TBL] [Abstract][Full Text] [Related]
24. Clonal hematopoiesis of indeterminate potential, DNA methylation, and risk for coronary artery disease.
Uddin MDM; Nguyen NQH; Yu B; Brody JA; Pampana A; Nakao T; Fornage M; Bressler J; Sotoodehnia N; Weinstock JS; Honigberg MC; Nachun D; Bhattacharya R; Griffin GK; Chander V; Gibbs RA; Rotter JI; Liu C; Baccarelli AA; Chasman DI; Whitsel EA; Kiel DP; Murabito JM; Boerwinkle E; Ebert BL; Jaiswal S; Floyd JS; Bick AG; Ballantyne CM; Psaty BM; Natarajan P; Conneely KN
Nat Commun; 2022 Sep; 13(1):5350. PubMed ID: 36097025
[TBL] [Abstract][Full Text] [Related]
25. Clinical consequences of clonal hematopoiesis of indeterminate potential.
Steensma DP
Hematology Am Soc Hematol Educ Program; 2018 Nov; 2018(1):264-269. PubMed ID: 30504320
[TBL] [Abstract][Full Text] [Related]
26. Prevalence and significance of clonal hematopoiesis of indeterminate potential in lung transplant recipients.
Swaminathan AC; Barfield R; Zhang M; Povysil G; Chen C; Frankel C; Kelly F; McKinney M; Todd JL; Allen A; Palmer SM
BMC Pulm Med; 2023 Oct; 23(1):414. PubMed ID: 37904125
[TBL] [Abstract][Full Text] [Related]
27. Common and rare variant associations with clonal haematopoiesis phenotypes.
Kessler MD; Damask A; O'Keeffe S; Banerjee N; Li D; Watanabe K; Marketta A; Van Meter M; Semrau S; Horowitz J; Tang J; Kosmicki JA; Rajagopal VM; Zou Y; Houvras Y; Ghosh A; Gillies C; Mbatchou J; White RR; Verweij N; Bovijn J; Parikshak NN; LeBlanc MG; Jones M; ; ; Glass DJ; Lotta LA; Cantor MN; Atwal GS; Locke AE; Ferreira MAR; Deering R; Paulding C; Shuldiner AR; Thurston G; Ferrando AA; Salerno W; Reid JG; Overton JD; Marchini J; Kang HM; Baras A; Abecasis GR; Jorgenson E
Nature; 2022 Dec; 612(7939):301-309. PubMed ID: 36450978
[TBL] [Abstract][Full Text] [Related]
28. Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease.
Jaiswal S; Natarajan P; Silver AJ; Gibson CJ; Bick AG; Shvartz E; McConkey M; Gupta N; Gabriel S; Ardissino D; Baber U; Mehran R; Fuster V; Danesh J; Frossard P; Saleheen D; Melander O; Sukhova GK; Neuberg D; Libby P; Kathiresan S; Ebert BL
N Engl J Med; 2017 Jul; 377(2):111-121. PubMed ID: 28636844
[TBL] [Abstract][Full Text] [Related]
29. Clonal Hematopoiesis of Indeterminate Potential and Cardiovascular Disease.
Kumar P; Kopecky SL; Yang EH; Oren O
Curr Oncol Rep; 2020 Jul; 22(9):87. PubMed ID: 32643015
[TBL] [Abstract][Full Text] [Related]
30. Clonal Hematopoiesis: Crossroads of Aging, Cardiovascular Disease, and Cancer: JACC Review Topic of the Week.
Libby P; Sidlow R; Lin AE; Gupta D; Jones LW; Moslehi J; Zeiher A; Jaiswal S; Schulz C; Blankstein R; Bolton KL; Steensma D; Levine RL; Ebert BL
J Am Coll Cardiol; 2019 Jul; 74(4):567-577. PubMed ID: 31345432
[TBL] [Abstract][Full Text] [Related]
31. Clonal hematopoiesis with DNMT3A mutation is associated with lower white matter hyperintensity volume.
Lee WJ; Jung KH; Song H; Lee H; Park HE; Koh Y; Choi SY; Park KI
CNS Neurosci Ther; 2023 May; 29(5):1243-1253. PubMed ID: 36807865
[TBL] [Abstract][Full Text] [Related]
32. Clonal hematopoiesis driven by DNMT3A and TET2 mutations: role in monocyte and macrophage biology and atherosclerotic cardiovascular disease.
Cobo I; Tanaka T; Glass CK; Yeang C
Curr Opin Hematol; 2022 Jan; 29(1):1-7. PubMed ID: 34654019
[TBL] [Abstract][Full Text] [Related]
33. Obesity-induced inflammation exacerbates clonal hematopoiesis.
Pasupuleti SK; Ramdas B; Burns SS; Palam LR; Kanumuri R; Kumar R; Pandhiri TR; Dave UP; Yellapu NK; Zhou X; Zhang C; Sandusky GE; Yu Z; Honigberg MC; Bick AG; Griffin GK; Niroula A; Ebert BL; Paczesny S; Natarajan P; Kapur R
J Clin Invest; 2023 Jun; 133(11):. PubMed ID: 37071471
[TBL] [Abstract][Full Text] [Related]
34. Genetics of smoking and risk of clonal hematopoiesis.
Levin MG; Nakao T; Zekavat SM; Koyama S; Bick AG; Niroula A; Ebert B; Damrauer SM; Natarajan P
Sci Rep; 2022 May; 12(1):7248. PubMed ID: 35508625
[TBL] [Abstract][Full Text] [Related]
35. High-sensitivity C-reactive protein is associated with clonal hematopoiesis of indeterminate potential.
Busque L; Sun M; Buscarlet M; Ayachi S; Feroz Zada Y; Provost S; Bourgoin V; Mollica L; Meisel M; Hinterleitner R; Jabri B; Dubé MP; Tardif JC
Blood Adv; 2020 Jun; 4(11):2430-2438. PubMed ID: 32492156
[TBL] [Abstract][Full Text] [Related]
36. Clonal hematopoiesis of indeterminate potential in patients with acute coronary syndrome undergoing percutaneous coronary intervention in the absence of traditional risk factors.
Jiang Z; Li Y; Yan C; Zhang X; Zhang Q; Li J; Tian X; Qiu M; Liang Z; Ma S; Na K; Li Z; Chen S; Zhao Y; Qi Z; Liu X; Han Y
Clin Res Cardiol; 2023 Apr; 112(4):506-517. PubMed ID: 35704087
[TBL] [Abstract][Full Text] [Related]
37. Clonal hematopoiesis and cardiovascular disease: deciphering interconnections.
Stein A; Metzeler K; Kubasch AS; Rommel KP; Desch S; Buettner P; Rosolowski M; Cross M; Platzbecker U; Thiele H
Basic Res Cardiol; 2022 Nov; 117(1):55. PubMed ID: 36355225
[TBL] [Abstract][Full Text] [Related]
38. Clonal haematopoiesis of indeterminate potential and cardiovascular events in systemic lupus erythematosus (HEMATOPLUS study).
David C; Duployez N; Eloy P; Belhadi D; Chezel J; Guern VL; Laouénan C; Fenwarth L; Rouzaud D; Mathian A; de Almeida Chaves S; Duhaut P; Fain O; Galicier L; Ghillani-Dalbin P; Kahn JE; Morel N; Perard L; Pha M; Sarrot-Reynauld F; Aumaitre O; Chasset F; Limal N; Desmurs-Clavel H; Ackermann F; Amoura Z; Papo T; Preudhomme C; Costedoat-Chalumeau N; Sacre K
Rheumatology (Oxford); 2022 Nov; 61(11):4355-4363. PubMed ID: 35176141
[TBL] [Abstract][Full Text] [Related]
39. Cardiovascular Disease Among Patients With AML and CHIP-Related Mutations.
Calvillo-Argüelles O; Schoffel A; Capo-Chichi JM; Abdel-Qadir H; Schuh A; Carrillo-Estrada M; Liu S; Gupta V; Schimmer AD; Yee K; Shlush LI; Natarajan P; Thavendiranathan P
JACC CardioOncol; 2022 Mar; 4(1):38-49. PubMed ID: 35492819
[TBL] [Abstract][Full Text] [Related]
40. Clonal hematopoiesis is associated with protection from Alzheimer's disease.
Bouzid H; Belk JA; Jan M; Qi Y; Sarnowski C; Wirth S; Ma L; Chrostek MR; Ahmad H; Nachun D; Yao W; ; Beiser A; Bick AG; Bis JC; Fornage M; Longstreth WT; Lopez OL; Natarajan P; Psaty BM; Satizabal CL; Weinstock J; Larson EB; Crane PK; Keene CD; Seshadri S; Satpathy AT; Montine TJ; Jaiswal S
Nat Med; 2023 Jul; 29(7):1662-1670. PubMed ID: 37322115
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
